Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

New insights into how Omicron variants avoid destruction by "killer" T cells

Omicron subvariants of SARS-CoV-2 - the virus behind COVID-19 - have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections.

11 Apr 2023

Radioimmunotherapy cures human non-Hodgkin lymphoma in animal model

A new nuclear medicine therapy can cure human non-Hodgkin lymphoma in an animal model, according to research published in the April issue of The Journal of Nuclear Medicine.

11 Apr 2023

A creative new approach to make vaccine against norovirus

Every year, norovirus causes hundreds of millions of cases of food poisoning - and the deaths of at least 50,000 children - yet there exists no real way to control it.

11 Apr 2023

Novel optical imaging approach provides four-dimensional view of cell secretions

Cell secretions like proteins, antibodies, and neurotransmitters play an essential role in immune response, metabolism, and communication between cells.

11 Apr 2023

Mutant Salmonella strains cause more severe infections than wild-type bacteria in chickens

In Brazil, a group of researchers supported by FAPESP created mutant forms of Salmonella to understand the mechanisms that favor colonization of the intestinal tract of chickens by these pathogenic bacteria and find better ways to combat the infection they cause.

11 Apr 2023

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Researchers found antibodies that neutralize all current SARS-CoV-2 variants.

11 Apr 2023

Antepartum vs. postpartum vaccination: which provides the most protection against SARS-CoV-2 in breastfed infants?

Researchers evaluated the efficacy of transplacental transfer of antibodies against SARS-CoV-2 to infants.

10 Apr 2023

Air pollution lowers COVID-19 vaccine immune response

In a recent study published in the journal Environmental Health Perspectives, researchers performed a population-level cohort study in Catalonia, Spain, to evaluate the association between exposure to air pollution for a prolonged duration and coronavirus disease 2019 (COVID-19) vaccine-induced antibody response.

9 Apr 2023

Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

A team led by researchers at Weill Cornell Medicine, the University of Wisconsin-Madison; Scripps Research and the University of Chicago has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including Omicron, the most recent.

7 Apr 2023

Discovery may change the way people think about immune strategies

The human body is capable of creating a vast, diverse repertoire of antibodies - the Y-shaped sniffer dogs of the immune system that can find and flag foreign invaders.

7 Apr 2023

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

Researchers assess the role of the live-attenuated vaccine sCPD9 in inducing systemic and mucosal immunity against SARS-CoV-2 variants.

6 Apr 2023

The economic burden of RSV infections in low and middle-income countries

Researchers discuss the cost-of-illness associated with RSV infections among children in low and middle-income countries.

6 Apr 2023

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Antibody News and Research

Further Reading

New insights into how Omicron variants avoid destruction by "killer" T cells

Radioimmunotherapy cures human non-Hodgkin lymphoma in animal model

A creative new approach to make vaccine against norovirus

Novel optical imaging approach provides four-dimensional view of cell secretions

Mutant Salmonella strains cause more severe infections than wild-type bacteria in chickens

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Antepartum vs. postpartum vaccination: which provides the most protection against SARS-CoV-2 in breastfed infants?

Air pollution lowers COVID-19 vaccine immune response

Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

Discovery may change the way people think about immune strategies

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

The economic burden of RSV infections in low and middle-income countries

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

The association between neutralizing antibody response breadth and long COVID symptoms

Active compound of a medicinal herb could help fight rheumatoid arthritis

Live attenuated nasal vaccine elicits superior immunity to SARS-CoV-2 variants in hamsters

Research provides new insights into the underlying disease mechanisms for polycystic kidney disease

Pre-existing immunity shapes mucosal SARS-CoV-2-specific antibody responses

Event guide: Targeted Therapies Partnering & Licensing Summit Asia eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo